Dual-Tracer 18F-FDG and 68Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy
Dual-tracer imaging reveals interlesion heterogeneity in prostate cancer, and SUV ratio may help predict early response to NHT.
Authors
- Xiangwei Wang (ORCID: https://orcid.org/0000-0001-8108-4979)
- Xuwei Liu (ORCID: https://orcid.org/0000-0003-4954-2751)
- Panli Li
- Junqiang Lei (ORCID: https://orcid.org/0000-0003-2530-1646)
- Shaoli Song (ORCID: https://orcid.org/0000-0003-2544-7522)
- Chang Liu (ORCID: https://orcid.org/0000-0002-5930-3255)
- Liyan Bai (ORCID: https://orcid.org/0000-0003-2542-0442)
- Yan Zuo
- Silong Hu
- Haoyao Guo
- Linjie Bian (ORCID: https://orcid.org/0000-0002-1709-2939)
Institutions
- Fudan University Shanghai Cancer Center (CN)
- Wuxi No.2 People's Hospital (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1097/rlu.0000000000005587
- Citations
- 8
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.35